Skip to main content
SpringerLink
Log in

Quality of Life in Hypertensive Patients

  • Chapter
Health-Related Quality of Life in Cardiovascular Patients

  • 962 Accesses

Abstract

The definition of health-related quality of life (HRQoL) includes the physical, psychological, and social aspects of positive wellbeing as well as the negative effects of illness, treatment, and infirmity. It refers to subjects’ appraisals of their current level of functioning and satisfaction with it compared with what they perceive to be “ideal”. HRQoL broadly encompasses those aspects of life which can influence or be influenced by “health”. Usually HRQoL domains include physical, social and cognitive functioning as well as emotional wellbeing [1]. From a clinical perspective, after the manifestation and/or diagnosis of disease, this means that all of these dimensions may be influenced by the “health status” of the individual. Thus, this relationship is multidimensional. That is, good health is the result of biological, psychological, and social wellbeing; a disturbance in any of these areas (e.g., biological), results in disease, affects the other areas of wellbeing, and influences HRQoL.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Osoba D (2005) Health-related quality of life outcomes in clinical trials. In: Fayers P, Hays R (eds.) Assessing quality of life in clinical trials. Methods and practice. Oxford University Press, New York, pp 259–274

    Google Scholar 

  2. Kearney PM, Whelton M, Reynolds K et al (2004) Worldwide prevalence of hypertension: a systematic review. J Hypertens 22:11–19

    Article  PubMed  CAS  Google Scholar 

  3. Pereira M, Lunet N, Azevedo A et al (2009) Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens 27:963–975

    Article  PubMed  CAS  Google Scholar 

  4. Zdrojewski T, Szpakowski P, Bandosz P et al (2004) Arterial hypertension in Poland in 2002. J Hum Hypertens 18:557–562

    Article  PubMed  CAS  Google Scholar 

  5. Egan BM, Zhao Y, Axon RN (2010) US trends in prevalence, awareness, treatment and control of hypertension, 1988–2008. JAMA 303:2043–2050

    Article  PubMed  CAS  Google Scholar 

  6. Campbel NR, Khan NA, Hill MD et al (2009) 2009 Canadian Hypertension Education Program recommendations: the scientific summary — an annual update. Can J Cardiol 25:271–277

    Article  Google Scholar 

  7. Wiklund IK (1996) Hypertension. In: Spilker B (ed) Quality of Life and Pharmacoeconomics in Clinical Trials. Lippincott-Raven Publishers, Philadelphia, pp 893–902

    Google Scholar 

  8. Coyne KS, Davis D, Frech F et al (2002) Health-related quality of life in patients treated for hypertension: areview of the literature from 1990–2000. Clin Ther 24:142–169

    Article  PubMed  Google Scholar 

  9. Addington-Hall J, Kalra L (2001) Who should measure quality of life? BMJ 322:1417–1420

    Article  PubMed  CAS  Google Scholar 

  10. Jachuck SJ, Brierly H, Jachuck S et al (1982) The effect of hypotensive drugs on the quality of life. J R Coll Gen Pract 32:103–105

    PubMed  CAS  Google Scholar 

  11. Hays RD (2005) Generic versus disease-targeted instruments. In: Fayers P, Hays R (eds.) Assessing quality of life in clinical trials. Methods and practice. Oxford University Press, New York, pp 3–8

    Google Scholar 

  12. Bardage C, Isacson DGL (2001) Hypertension and health-related quality of life: an epidemiological study in Sweden. J Clin Epidemiol 54:172–181

    Article  PubMed  CAS  Google Scholar 

  13. Roca-Cusachs A, Dalfo A, Badia X et al (2001) Relation between clinical and therapeutic variables and quality of life in hypertension. J Hypertens 19:1913–1919

    Article  PubMed  CAS  Google Scholar 

  14. Mena-Martin FJ, Martin-Escudero JC, Simal-Blanco F et al (2003) Health-related quality of life of subjects with known and unknown hypertension: results from the population-based Hortega study. J Hypertens 21:1283–1289

    Article  PubMed  CAS  Google Scholar 

  15. Klocek M, Kawecka-Jaszcz K (2003) Quality of life in patients with arterial hypertension. Part I: The effect of socio-demographic factors. Przegl Lek 60:92–100

    PubMed  Google Scholar 

  16. Erickson SR, Williams BC, Gruppen LD (2001) Perceived symptoms and health-related quality of life reported by uncomplicated hypertensive patients compared to normal controls. J Hum Hypertens 15:539–548

    Article  PubMed  CAS  Google Scholar 

  17. Klocek M, Kawecka-Jaszcz K (2003) Quality of life in patients with arterial hypertension. Part I: The effect of clinical factors. Przegl Lek 60:101–106

    PubMed  Google Scholar 

  18. Battersby C, Hartlery K, Fletcher AE (1995) Quality of life in treated hypertension: a case-control community based study. J Hum Hypertens 9:854–859

    Google Scholar 

  19. Mold JW, Hamm RM, Jafri B (2000) The effect of labeling on perceived ability to recover from acute illnesses and injures. J Fam Pract 49:437–440

    PubMed  CAS  Google Scholar 

  20. Coelho R, Santos A, Ribeiro L et al (1999) Differences in behavior profile between normotensive subject and patients with white-coat and sustained hypertension. J Psychosom Res 46:15–27

    Article  PubMed  CAS  Google Scholar 

  21. Trevisol DJ, Moreira LB, Fuchs FD etal (2011) Health-related quality of life is worse in individuals with hypertension under drug treatment: results of population-based study. J Hum Hypertens 26:374–380

    Article  PubMed  Google Scholar 

  22. Trevisol DJ, Moreira LB, Kerkhoff A et al (2011) Health-related quality of life and hypertension: a systematic review and meta-analysis of observational studies. J Hypertens 29:179–188

    Article  PubMed  CAS  Google Scholar 

  23. Korhonen PE, Kivelä SL, Kautiainen H et al (2011) Health-related quality of life and awareness of hypertension. J Hypertens 29:2070–2074

    Article  PubMed  CAS  Google Scholar 

  24. Levenstein S, Smith MW, Kaplan GA (2001) Psychosocial predictors of hypertension in men and women. Arch Intern Med 161:1341–1346

    Article  PubMed  CAS  Google Scholar 

  25. Hansson L for the BBB Study Group (1994) The BBB Study: the effect of intensified antihypertensive treatment on the level of blood pressure, side-effects, morbidity and mortality in “well-treated” hypertensive patients. Blood Pres 3:248–254

    Article  Google Scholar 

  26. Wassertheil-Smoller S, Blaufox MD, Oberman A et al (1991) Effect of antihypertensives on sexual function and quality of life: the TAIM Study. An Intern Med 114:613–620

    Article  CAS  Google Scholar 

  27. Grimm RH, Grandits GA, Cutler JA et al (1997) Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study (TOMHS). Arch Intern Med 157:638–648

    Article  PubMed  Google Scholar 

  28. Wilkund IK, Halling K, Ryden-Bergsten T et al (1997) Does lowering the blood pressure improve the mood? Quality-of-life results from the Hypertension Optimal Treatment (HOT) Study. Blood Pres 6:357–364

    Article  Google Scholar 

  29. Tedesco MA, Di Salvo G, Caputo S (2001) Educational level and hypertension: how socioe-conomic differences condition health care. J Hum Hypertens 15:727–731

    Article  PubMed  CAS  Google Scholar 

  30. Pająk A, Klocek M, Grodzicki T et al (1999) Adverse symptoms and effectiveness of treatment of essential arterial hypertension. Nadciśnienie Tętnicze 3:182–191

    Google Scholar 

  31. Forette F, Seux ML, Staessen JA et al (1998) Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 352:1347–1351

    Article  PubMed  CAS  Google Scholar 

  32. Agewall S, Wilkstrand J, Fagerberg B (1998) Stroke was predicted by dimensions of quality of life in treated hypertensive men. Stroke 29:2329–2333

    Article  PubMed  CAS  Google Scholar 

  33. Grimm RH, Grandits GA, Prineas RJ et al (1997) Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women: Treatment of Mild Hypertension Study (TOMHS). Hypertension 29:8–14

    Article  PubMed  CAS  Google Scholar 

  34. Paran E, Anson O, Neumann L (1996) The effects of diuretics on quality of life of hypertensive patients. J Hum Hypertens 10:147–152

    Google Scholar 

  35. Guez D, Crocq L, Sefavian A et al (1988) Effects of indapamide on the quality of life of hypertensive patients. Am J Med 84:53–58

    PubMed  CAS  Google Scholar 

  36. Van Bortel LM, Bulpitt CJ, Fici F (2005) Quality of life and antihypertensive effect with nebivolol and losartan. Am J Hypertens 18:1060–1066

    Article  PubMed  Google Scholar 

  37. Bulpitt CJ, Connor M, Schulte M et al (2000) Bisoprolol and nifedipine retard in elderly hypertensive patients: effect on quality of life. J Hum Hypertens 14:205–212

    Article  PubMed  CAS  Google Scholar 

  38. Omvik P, Thaulow E, Herland OB et al (1993) Double-blind, parallel, comparative study on quality of life during treatment with amlodipine and enalapril in mild or moderate hypertensive patients: a multicenter study. J Hypertens 11:103–113

    Article  PubMed  CAS  Google Scholar 

  39. Omvik P, Herland OB, Thaulow E et al (1995) Evaluation and quality of life assessment of amlodipine and enalapril in patients with hypertension. J Hum Hypertens 9:17–24

    Google Scholar 

  40. Klocek M., Czarnecka D (2001) Impact of amlodipine and enalapril on quality of life in patients with essential hypertension. Nadciśnienie Tętnicze 1:1–8

    Google Scholar 

  41. Weir MR, Pristant LM, Papademetriou V et al (1996) Antihypertensive therapy and quality of life. Influence of blood pressure reduction, adverse events and prior antihypertensive therapy. Am J Hypertens 9:854–859

    Article  PubMed  CAS  Google Scholar 

  42. Leonetti G, Magnani B, Pessina AC et al (2002) Tolerability of long-term treatment with lercanidipine versus amlodipine and lacidipine in elderly hypertensives. Am J Hypertens 15:932–940

    Article  PubMed  CAS  Google Scholar 

  43. Yodfat Y, Bar-On D, Amir M et al (1996) Quality of life in normotensive compared with hypertensive men treated with isradipine or methyldopa as monotherapy or in combination with captopril: the LOMIR-MCT-IL study. J Hum Hypertens 10:117–122

    PubMed  CAS  Google Scholar 

  44. Staessen JA, Fagard R, Thijs L et al (1997) Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 350:757–764

    Article  PubMed  CAS  Google Scholar 

  45. Fletcher AE, Bulpitt CJ, Thijs L et al (2002) Quality of life on randomized treatment for isolated systolic hypertension: results from the Syst — Eur Trial. J Hypertens 20:2069–2079

    Article  PubMed  CAS  Google Scholar 

  46. Bulpitt CJ, Beckett NS, Fletcher AE et al (2002) Withdrawal from treatment in the Syst-Eur Trial. J Hypertens 20:339–346

    Article  PubMed  CAS  Google Scholar 

  47. Croog SH, Levine S, Testa MA et al (1986) The effect of antihypertensive therapy on quality of life. N Engl J Med 314:1657–1663

    Article  PubMed  CAS  Google Scholar 

  48. Testa MA, Anderson RB, Nanckey JF et al (1993) Quality of life and antihypertensive therapy in men: a comparison of captopril and enalapril. N Engl J Med 328:907–913

    Article  PubMed  CAS  Google Scholar 

  49. Fogari R, Zoppi A, Corradi L et al (1998) Sexual function in hypertensive males treated with lisinopril and atenolol: a cross-over study. Am J Hypertens 11:1244–1247

    Article  PubMed  CAS  Google Scholar 

  50. Esposti LD, Di Martino M, Saragoni S et al (2004) Pharmacoeconomics of antihypertensive drug treatment: and how long patients remain on various antihypertensive therapy. J Clin Hypertens 6:76–82

    Article  Google Scholar 

  51. Dahlof B, Lindholm LH, Carney S et al (1997) Main results of the losartan versus amlodipine (LOA) study on drug tolerability and psychological general well-being. LOA Study Group. J Hypertens 15:1327–1335

    Article  PubMed  CAS  Google Scholar 

  52. Mugellini A, Preti P, Marasi G et al (2003) Influence of valsartan and enalapril on cognitive function in elderly hypertensive patients. Am J Hypertens 16:27A

    Article  Google Scholar 

  53. Fogari R, Preti P, Zoppi A et al (2004) Effect of valsartan and atenolol on sexual behavior in hypertensive postmenopausal women. Am J Hypertens 17:77–81

    Article  PubMed  CAS  Google Scholar 

  54. Weber MA, Barkis GL, Neutel JM et al (2003) Quality of life measured in a practice-based hypertension trial of an angiotensin receptor blocker. J Clin Hypertens 5:322–329

    CAS  Google Scholar 

  55. Schmidt AC, Bramlage P, Limberg R et al (2008) Quality of life in hypertension management using olmesartan in primary care. Expert Opin Pharmacother 9:1641–1653

    Article  PubMed  CAS  Google Scholar 

  56. Williams SA, Michelson EL, Cain VA et al (2008) An evaluation of the effects of an angiotensin receptor blocker on health-related quality of life in patients with high-normal blood pressure (prehypertension) in the Trial of Preventing Hypertension (TROPHY). J Clin Hypertens 10:436–442

    Article  Google Scholar 

  57. Martell N, Luque M (2001) Doxazosin added to single-drug therapy in hypertensive patients with benign prostatic hypertrophy. J Clin Hypertens 3:218–223

    Article  CAS  Google Scholar 

  58. Piha J, Kaaja R (2003) Effects of moxonidine and metoprolol in penile circulation in hypertensive men with erectile dysfunction: results of a pilot study. Intern J Impot Res 15:287–289

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. I Department of Cardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland

    Marek Klocek

Authors
  1. Marek Klocek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kalina Kawecka-Jaszcz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marek Klocek .

Editor information

Editors and Affiliations

  1. I Department of Cardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland

    Kalina Kawecka-Jaszcz (Professor of Cardiology and Internal Medicine) & Marek Klocek (Associate Professor of Internal Medicine) (Professor of Cardiology and Internal Medicine) &  (Associate Professor of Internal Medicine)

  2. Epidemiology and Preventive Medicine, Jagiellonian University Medical College, Kraków, Poland

    Beata Tobiasz-Adamczyk (Professor of Sociology, Chair) (Professor of Sociology, Chair)

  3. Medicine Experimental Medicine (Care of the Elderly), Division of Medicine, Imperial College London, Hammersmith Campus, London, UK

    Christopher J. Bulpitt (Professor of Geriatric and Cardiovascular) (Professor of Geriatric and Cardiovascular)

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Italia

About this chapter

Cite this chapter

Klocek, M., Kawecka-Jaszcz, K. (2013). Quality of Life in Hypertensive Patients. In: Kawecka-Jaszcz, K., Klocek, M., Tobiasz-Adamczyk, B., Bulpitt, C.J. (eds) Health-Related Quality of Life in Cardiovascular Patients. Springer, Milano. https://doi.org/10.1007/978-88-470-2769-5_2

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2769-5_2

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-2768-8

  • Online ISBN: 978-88-470-2769-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation